Integrative Single-Cell and Spatial Transcriptomic Analysis Identifies a Tertiary Lymphoid Structure-Associated LAMP3+CCR7+ mregDC Antigen-Presentation Program in Ovarian Cancer
Cancers · 14.07.2026 · 18 (14) · 2259
DOI: 10.3390/cancers18142259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 14.07.2026. Verfasst von Feifan Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Changhai Hospital, Naval Medical University, Shanghai 200433, China. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changhai Hospital, Foundation of Changhai Hospital.
Abstract (Originalsprache)
Background
Tertiary lymphoid structures (TLSs) are spatial immune niches in solid tumors, but their relationship to mature regulatory dendritic-cell (mregDC) states in ovarian cancer remains incompletely resolved.
Methods
We integrated public gynecological-tumor single-cell RNA sequencing, representative CD11C/HLA-DRA/LAMP3/CCR7 multiplex immunofluorescence, public Xenium and multi-sample spatial transcriptomics, TCGA-OV immune deconvolution and exploratory prognostic modeling, scTenifoldKnk and CellOracle perturbation analyses, and supplementary computational drug prioritization.
Results
A LAMP3+CCR7+ dendritic-cell state showed mature migratory, antigen-presentation, checkpoint, and NF-κB/TNF-associated programs. Spatial analyses linked TLS-score-defined regions to mregDC, antigen-presentation/MHC-II proxy, and interferon-associated signals, with distance-gradient analyses supporting TLS-proximal enrichment. Immune deconvolution associated the TLS/mregDC axis with an immune-infiltrated TCGA-OV contexture, whereas adjusted analyses emphasized dependence on broader immune-program richness. Perturbation analyses nominated candidate regulatory axes for experimental testing, and the supplementary drug-prioritization layer was retained only as target-class hypothesis support.
Conclusions
These data support a hypothesis-generating model of a TLS-associated LAMP3+CCR7+ mregDC antigen-presentation program in ovarian cancer, while requiring raw-channel tissue validation, functional perturbation, and independent clinical testing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
- Department of Hematology, Shanghai East Hospital, Tongji University, Shanghai 200120, China.
- National Facility for Translational Medicine (Beijing), Medical Innovation Research Division, PLA General Hospital, Beijing 100853, China.
- Department of Pathology, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
Förderung
- Changhai Hospital
- Foundation of Changhai Hospital
Zitieren
APA
Lu, F., Zhang, T., Li, Z., Yao, R., Hu, H., Guan, R., & Xu, M. (2026). Integrative Single-Cell and Spatial Transcriptomic Analysis Identifies a Tertiary Lymphoid Structure-Associated LAMP3+CCR7+ mregDC Antigen-Presentation Program in Ovarian Cancer. Cancers, 18(14), 2259. https://doi.org/10.3390/cancers18142259
Vancouver
Lu F, Zhang T, Li Z, Yao R, Hu H, Guan R, et al. Integrative Single-Cell and Spatial Transcriptomic Analysis Identifies a Tertiary Lymphoid Structure-Associated LAMP3+CCR7+ mregDC Antigen-Presentation Program in Ovarian Cancer. Cancers. 2026;18(14):2259. doi:10.3390/cancers18142259
BibTeX
@article{Lu2026,
author = {Lu, Feifan and Zhang, Ting and Li, Zhixuan and Yao, Renqi and Hu, Hao and Guan, Rui and Xu, Mingjuan},
title = {Integrative Single-Cell and Spatial Transcriptomic Analysis Identifies a Tertiary Lymphoid Structure-Associated LAMP3+CCR7+ mregDC Antigen-Presentation Program in Ovarian Cancer},
journal = {Cancers},
year = {2026},
volume = {18},
number = {14},
pages = {2259},
doi = {10.3390/cancers18142259}
}
EUVIMED